YIH
FOLD

Y-Intercept (HK)’s Amicus Therapeutics FOLD Stock Holding History

Y-Intercept (HK)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-149,771
Closed -$2.13M – 1722
2025
Q4 		$2.13M Sell
149,771
-113,468
-43% -$1.11M 0.05% 595
2025
Q3 		$2.07M Sell
263,239
-723,540
-73% -$5.15M 0.05% 581
2025
Q2 		$5.65M Buy
986,779
+965,328
+4,500% +$6.23M 0.14% 184
2025
Q1 		$175K Sell
21,451
-99,507
-82% -$921K 0.01% 1073
2024
Q4 		$1.14M Buy
120,958
+85,951
+246% +$893K 0.08% 375
2024
Q3 		$374K Sell
35,007
-68,109
-66% -$742K 0.02% 918
2024
Q2 		$1.02M Buy
103,116
+35,875
+53% +$368K 0.06% 483
2024
Q1 		$792K Buy
+67,241
New +$860K 0.06% 483
2023
Q4 		– Sell
-24,170
Closed -$294K – 1375
2023
Q3 		$294K Sell
24,170
-11,554
-32% -$149K 0.03% 781
2023
Q2 		$449K Buy
35,724
+20,168
+130% +$239K 0.05% 597
2023
Q1 		$173K Sell
15,556
-54,651
-78% -$674K 0.02% 998
2022
Q4 		$857K Buy
70,207
+21,708
+45% +$244K 0.13% 248
2022
Q3 		$506K Buy
48,499
+29,483
+155% +$329K 0.05% 535
2022
Q2 		$204K Buy
+19,016
New +$157K 0.03% 681
2022
Q1 		– Sell
-17,431
Closed -$201K – 796
2021
Q4 		$201K Buy
+17,431
New +$194K 0.05% 517
2021
Q3 		– Sell
-16,435
Closed -$158K – 734
2021
Q2 		$158K Sell
16,435
-45,637
-74% -$445K 0.04% 547
2021
Q1 		$583K Buy
62,072
+47,475
+325% +$735K 0.16% 206
2020
Q4 		$335K Buy
+14,597
New +$299K 0.14% 274

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Y-Intercept (HK)'s FOLD Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 149,771 shares — an estimated $2.13M sold.

Y-Intercept (HK) first reported a position in FOLD in Q4 2020 and held it in 18 quarters. The position peaked at $5.65M in Q2 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 149,771 Amicus Therapeutics shares in Q1 2026, an estimated $2.13M.
  • Y-Intercept (HK) first reported a position in Amicus Therapeutics in Q4 2020 and held it in 18 quarters.
  • Y-Intercept (HK)'s Amicus Therapeutics position peaked at $5.65M in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.